Breast cancer is one of the most public and fatal malignancy worldwide. One of the main cytokines playing a role in breast cancer progression is TGF1. In this study we aimed to determine the clinical significance of the serum TGFβ1 levels in breast cancer patients by comparing the levels of TGFβ1 in breast cancer patients and in control females, assessment of the levels of TGFβ1 in diagnosed breast cancer patients before and after treatment and correlating between the levels of TGFβ1 in breast cancer patients with the laboratory and radiological findings. | Transforming growth factor Beta 1 TGFβ1 as an immunological marker in breast cancer patients
